These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Ovarian recovery after stem cell transplantation. Liu J; Malhotra R; Voltarelli J; Stracieri AB; Oliveira L; Simoes BP; Ball ED; Carrier E Bone Marrow Transplant; 2008 Feb; 41(3):275-8. PubMed ID: 17952128 [TBL] [Abstract][Full Text] [Related]
28. Cerebral toxoplasmosis after tandem high-dose chemotherapy and autologous hematopoietic cell transplant for neuroblastoma. Voegele L; Cheerva AC; Bertolone S J Pediatr Hematol Oncol; 2013 Mar; 35(2):e50-2. PubMed ID: 22995924 [TBL] [Abstract][Full Text] [Related]
29. Toxoplasmosis after renal transplantation. Herb HM; Jontofsohn R; Löffler HD; Heinze V Clin Nephrol; 1977 Dec; 8(6):529-32. PubMed ID: 340086 [TBL] [Abstract][Full Text] [Related]
30. Fatal disseminated toxoplasmosis in a cardiac transplantation with seropositive match for Toxoplasma: should prophylaxis be extended? Castagnini M; Bernazzali S; Ginanneschi C; Marchi B; Maccherini M; Tsioulpas C; Tanganelli P Transpl Immunol; 2007 Nov; 18(2):193-7. PubMed ID: 18005867 [TBL] [Abstract][Full Text] [Related]
31. Resolution of SLE-related soft-tissue calcification following haematopoietic stem cell transplantation. Mandelbrot DA; Santos PW; Burt RK; Oyama Y; Block GA; Ahya SN; Rosa RM; Traynor AE Nephrol Dial Transplant; 2008 Aug; 23(8):2679-84. PubMed ID: 18326564 [TBL] [Abstract][Full Text] [Related]
32. Management of bacteremia in patients undergoing hematopoietic stem cell transplantation. Castagnola E; Faraci M Expert Rev Anti Infect Ther; 2009 Jun; 7(5):607-21. PubMed ID: 19485800 [TBL] [Abstract][Full Text] [Related]
33. [Prevention of toxoplasmosis in immunocompromised patients]. Morlat P; Leport C Ann Med Interne (Paris); 1997; 148(3):235-9. PubMed ID: 9255332 [TBL] [Abstract][Full Text] [Related]
34. Clinical and diagnostic management of toxoplasmosis in the immunocompromised patient. Contini C Parassitologia; 2008 Jun; 50(1-2):45-50. PubMed ID: 18693556 [TBL] [Abstract][Full Text] [Related]
35. Toxoplasmosis in immunocompromized patients. Edvinsson B; Lappalainen M; Anttila VJ; Paetau A; Evengård B Scand J Infect Dis; 2009; 41(5):368-71. PubMed ID: 19229764 [TBL] [Abstract][Full Text] [Related]
36. Systemic toxoplasmosis post allogeneic stem cell transplantation (Allo-SCT): lessons learned from HIV? von Lilienfeld-Toal M; Gilleece M; Cook G Biol Blood Marrow Transplant; 2007 Jul; 13(7):871-2. PubMed ID: 17580266 [No Abstract] [Full Text] [Related]
37. Haematopoietic stem cell transplantation for autoimmune disorders. Saccardi R; Di Gioia M; Bosi A Curr Opin Hematol; 2008 Nov; 15(6):594-600. PubMed ID: 18832930 [TBL] [Abstract][Full Text] [Related]
38. Busulfan and cyclophosphamide (Bu/Cy) as a preparative regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma: a single-institution experience. Ulrickson M; Aldridge J; Kim HT; Hochberg EP; Hammerman P; Dube C; Attar E; Ballen KK; Dey BR; McAfee SL; Spitzer TR; Chen YB Biol Blood Marrow Transplant; 2009 Nov; 15(11):1447-54. PubMed ID: 19822305 [TBL] [Abstract][Full Text] [Related]
39. Acute exacerbation of Toxoplasma gondii infection after hematopoietic stem cell transplantation: five case reports among 279 recipients. Sumi M; Aosai F; Norose K; Takeda W; Kirihara T; Sato K; Fujikawa Y; Shimizu I; Ueki T; Hirosima Y; Ueno M; Ichikawa N; Watanabe M; Kobayashi H Int J Hematol; 2013 Aug; 98(2):214-22. PubMed ID: 23749548 [TBL] [Abstract][Full Text] [Related]
40. Clinical characteristics and computed tomography findings of pulmonary toxoplasmosis after hematopoietic stem cell transplantation. Sumi M; Norose K; Hikosaka K; Kaiume H; Takeda W; Kirihara T; Kurihara T; Sato K; Ueki T; Hiroshima Y; Kuraishi H; Watanabe M; Kobayashi H Int J Hematol; 2016 Dec; 104(6):729-740. PubMed ID: 27531150 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]